chr3-184372618-C-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_000460.4(THPO):c.957G>C(p.Gln319His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,613,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000460.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
THPO | NM_000460.4 | c.957G>C | p.Gln319His | missense_variant | 6/6 | ENST00000647395.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
THPO | ENST00000647395.1 | c.957G>C | p.Gln319His | missense_variant | 6/6 | NM_000460.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 151922Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000999 AC: 25AN: 250268Hom.: 0 AF XY: 0.0000740 AC XY: 10AN XY: 135172
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1461392Hom.: 0 Cov.: 34 AF XY: 0.0000495 AC XY: 36AN XY: 726940
GnomAD4 genome AF: 0.000151 AC: 23AN: 151922Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74188
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 18, 2023 | Variant summary: THPO c.957G>C (p.Gln319His) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0001 in 250268 control chromosomes (gnomAD). To our knowledge, no occurrence of c.957G>C in individuals affected with THPO-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2022 | The c.957G>C (p.Q319H) alteration is located in exon 6 (coding exon 5) of the THPO gene. This alteration results from a G to C substitution at nucleotide position 957, causing the glutamine (Q) at amino acid position 319 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2023 | This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 319 of the THPO protein (p.Gln319His). This variant is present in population databases (rs144745352, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with THPO-related conditions. ClinVar contains an entry for this variant (Variation ID: 2160517). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at